IDEXX 연구소, Inc.
DE ˙ XTRA ˙ US45168D1046
€490.30 ↑19.90 (4.23%)
2026-06-04
주가
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionSpinnaker Trust
Latest Disclosed Ownership6,072 shares
Latest Disclosed Value $ 3,411,796
Spinnaker Trust reports 6.83% decrease in ownership of IX1 / IDEXX Laboratories, Inc.

On April 23, 2026 - Spinnaker Trust filed a 13F-HR form disclosing ownership of 6,072 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $2,963,136 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 6,517 shares of IDEXX Laboratories, Inc.. This represents a change in shares of -6.83% during the quarter. The current value of the position is $2,977,102 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F Idexx Laboratories Equities 45168D104 6,072 -445 -6.83 3,412 -22.62 0.1888
2026-02-10 2025-12-31 13F Idexx Laboratories Equities 45168D104 6,517 2,182 50.33 4,409 59.19 0.2360
2025-11-05 2025-09-30 13F Idexx Laboratories Equities 45168D104 4,335 -76 -1.72 2,770 17.08 0.1537
2025-08-04 2025-06-30 13F Idexx Laboratories Equities 45168D104 4,411 -450 -9.26 2,366 15.87 0.1423
2025-04-25 2025-03-31 13F Idexx Laboratories Equities 45168D104 4,861 200 4.29 2,041 5.92 0.1332
2025-01-30 2024-12-31 13F Idexx Laboratories Equities 45168D104 4,661 -70 -1.48 1,927 -19.37 0.1215
2024-10-31 2024-09-30 13F Idexx Laboratories Equities 45168D104 4,731 -547 -10.36 2,390 -7.04 0.1473
2024-07-31 2024-06-30 13F Idexx Laboratories Equities 45168D104 5,278 0 0.00 2,571 -9.76 0.1647
2024-05-06 2024-03-31 13F Idexx Laboratories Equities 45168D104 5,278 -1,544 -22.63 2,850 -24.75 0.1840
2024-02-02 2023-12-31 13F Idexx Laboratories Equities 45168D104 6,822 -2,315 -25.34 3,787 -5.23 0.2576
2023-11-08 2023-09-30 13F Idexx Laboratories Equities 45168D104 9,137 365 4.16 3,995 -9.31 0.3007
2023-08-01 2023-06-30 13F Idexx Laboratories Equities 45168D104 8,772 -785 -8.21 4,406 -7.83 0.3200
2023-04-13 2023-03-31 13F Idexx Laboratories Equities 45168D104 9,557 -6,646 -41.02 4,779 79,550.00 0.3622
2023-02-02 2022-12-31 13F Idexx Laboratories Equities 45168D104 16,203 -519 -3.10 7 -99.89 0.5151
2022-10-28 2022-09-30 13F Idexx Laboratories Equities 45168D104 16,722 333 2.03 5,448 -5.22 0.4517
2022-07-25 2022-06-30 13F Idexx Laboratories Equities 45168D104 16,389 2,054 14.33 5,748 -26.70 0.4434
2022-05-02 2022-03-31 13F Idexx Laboratories Equities 45168D104 14,335 97 0.68 7,842 -16.36 0.5288
2022-01-31 2021-12-31 13F Idexx Laboratories Equities 45168D104 14,238 835 6.23 9,376 12.49 0.6006
2021-11-02 2021-09-30 13F Idexx Laboratories Equities 45168D104 13,403 132 0.99 8,335 -0.55 0.5798
2021-08-09 2021-06-30 13F Idexx Laboratories Equities 45168D104 13,271 -265 -1.96 8,381 26.54 0.5838
2021-04-30 2021-03-31 13F Idexx Laboratories Equities 45168D104 13,536 85 0.63 6,623 -1.49 0.4970
2021-01-26 2020-12-31 13F Idexx Laboratories Equities 45168D104 13,451 -532 -3.80 6,723 22.33 0.5360
2020-10-27 2020-09-30 13F Idexx Laboratories Equities 45168D104 13,983 87 0.63 5,496 19.84 0.4872
2020-07-21 2020-06-30 13F Idexx Laboratories Equities 45168D104 13,896 967 7.48 4,586 46.47 0.4347
2020-05-05 2020-03-31 13F Idexx Laboratories Equities 45168D104 12,929 5,133 65.84 3,131 53.86 0.3443
2020-02-05 2019-12-31 13F Idexx Laboratories Equities 45168D104 7,796 -463 -5.61 2,035 -9.35 0.1859
2019-11-12 2019-09-30 13F Idexx Laboratories Equities 45168D104 8,259 13 0.16 2,245 -1.10 0.2215
2019-07-11 2019-06-30 13F Idexx Laboratories Equities 45168D104 8,246 75 0.92 2,270 24.25 0.2280
2019-04-29 2019-03-31 13F Idexx Laboratories Equities 45168D104 8,171 0 0.00 1,827 20.28 0.1836
2019-02-04 2018-12-31 13F Idexx Laboratories Equities 45168D104 8,171 39 0.48 1,519 -25.17 0.1725
2018-10-23 2018-09-30 13F Idexx Laboratories Equities 45168D104 8,132 3,582 78.73 2,030 104.84 0.2006
2018-08-02 2018-06-30 13F Idexx Laboratories Equities 45168D104 4,550 200 4.60 991 19.11 0.1056
2018-05-10 2018-03-31 13F Idexx Laboratories Equities 45168D104 4,350 -150 -3.33 832 18.35 0.0905
2018-02-09 2017-12-31 13F Idexx Laboratories Equities 45168D104 4,500 0 0.00 703 0.57 0.0816
2017-10-26 2017-09-30 13F Idexx Laboratories Equities 45168D104 4,500 0 0.00 699 -3.72 0.0873
2017-07-27 2017-06-30 13F Idexx Laboratories Com 45168D104 4,500 0 0.00 726 4.31 0.0907
2017-05-10 2017-03-31 13F Idexx Laboratories Com 45168D104 4,500 0 0.00 696 31.82 0.0904
2017-02-15 2016-12-31 13F Idexx Laboratories Com 45168D104 4,500 4,500 528 0.0710
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.